NetworkNewsBreaks – No Borders, Inc.’s (NBDR)
Post# of 68
(Total Views: 222)
Posted On: 03/24/2020 4:04:19 PM
NetworkNewsBreaks – No Borders, Inc.’s (NBDR) MediDent Supplies Announces New Stay at Home 15 Minute Rapid Result COVID-19 Blood Tests
No Borders (OTC: NBDR) on Monday announced that the Company has executed an agreement with its existing suppliers in Hong Kong to bring its 15 minute “At Home” Serological COVID-19 test to the USA. According to the update, the brand new “MediDent Supplies 15 Minute Rapid Result Covid-19 Test” is being manufactured by a MediDent Supplies partner with existing U.S. FDA registrations for both the manufacturer and the serological test kit itself. MediDent Supplies is actively engaged with the FDA to obtain an Emergency Use Authorization for its COVID-19 blood test and believes it will receive expedited approval due to a recent update to the FDA COVID-19 testing guidelines, which now include serological testing. “Our entire team is committed to deploying every ounce of effort we can to help America through this trying time,” MediDent Supplies CEO Joseph Snyder said in the news release. “Millions of people around the world have used these serological tests to identify COVID-19 antibodies in the blood and these tests will have a dramatic impact on America’s ability to scale national real time testing efforts with a proven, effective blood test.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
No Borders (OTC: NBDR) on Monday announced that the Company has executed an agreement with its existing suppliers in Hong Kong to bring its 15 minute “At Home” Serological COVID-19 test to the USA. According to the update, the brand new “MediDent Supplies 15 Minute Rapid Result Covid-19 Test” is being manufactured by a MediDent Supplies partner with existing U.S. FDA registrations for both the manufacturer and the serological test kit itself. MediDent Supplies is actively engaged with the FDA to obtain an Emergency Use Authorization for its COVID-19 blood test and believes it will receive expedited approval due to a recent update to the FDA COVID-19 testing guidelines, which now include serological testing. “Our entire team is committed to deploying every ounce of effort we can to help America through this trying time,” MediDent Supplies CEO Joseph Snyder said in the news release. “Millions of people around the world have used these serological tests to identify COVID-19 antibodies in the blood and these tests will have a dramatic impact on America’s ability to scale national real time testing efforts with a proven, effective blood test.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)